Title : HCV in Southeast Asia - Ledipasvir and Sofosbuvir for HCV Genotype 6
link : HCV in Southeast Asia - Ledipasvir and Sofosbuvir for HCV Genotype 6
HCV in Southeast Asia - Ledipasvir and Sofosbuvir for HCV Genotype 6
Kenneth Bender
The successful treatment of hepatitis C virus genotype 6 (HCV-GT6) with a non-interferon-based fixed dose oral regimen of ledipasvir and sofosbuvir (LDV/SOF) bodes well for treating HCV in Southeast Asia, where newer pangenotypic agents are not available to treat this region's most prevalent genotype.
Thus Article HCV in Southeast Asia - Ledipasvir and Sofosbuvir for HCV Genotype 6
That's an article HCV in Southeast Asia - Ledipasvir and Sofosbuvir for HCV Genotype 6 This time, hopefully can give benefits to all of you. well, see you in posting other articles.
You are now reading the article HCV in Southeast Asia - Ledipasvir and Sofosbuvir for HCV Genotype 6 with the link address https://theleknews.blogspot.com/2018/01/hcv-in-southeast-asia-ledipasvir-and.html
0 Response to "HCV in Southeast Asia - Ledipasvir and Sofosbuvir for HCV Genotype 6"
Post a Comment